Cargando…

Antigenic evolution of SARS-CoV-2 in immunocompromised hosts

Objectives/aims: Prolonged infections of immunocompromised individuals have been proposed as a crucial source of new variants of SARS-CoV-2 during the COVID-19 pandemic. In principle, sustained within-host antigenic evolution in immunocompromised hosts could allow novel immune escape variants to eme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smith, Cameron A, Ashby, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061940/ https://www.ncbi.nlm.nih.gov/pubmed/37007166 http://dx.doi.org/10.1093/emph/eoac037

Ejemplares similares

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

SARS-CoV-2 vaccination in the immunocompromised host
por: Connolly, Caoilfhionn M., et al.
Publicado: (2022)

SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
por: Clark, Sarah A., et al.
Publicado: (2021)

SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient
por: Quaranta, Erika Giorgia, et al.
Publicado: (2022)

Monitoring and managing SARS-CoV-2 evolution in immunocompromised populations
por: Li, Pengfei, et al.
Publicado: (2022)

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
por: Scherer, Erin M., et al.
Publicado: (2022)

SARS-CoV-2 in immunocompromised individuals
por: DeWolf, Susan, et al.
Publicado: (2022)

Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland
por: Lynch, Maureen, et al.
Publicado: (2021)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
por: Raglow, Zoe, et al.
Publicado: (2023)

SARS-CoV-2 late shedding may be infectious between immunocompromised hosts
por: Kaila, Ville, et al.
Publicado: (2021)

SARS-CoV-2 coinfection in immunocompromised host leads to the generation of recombinant strain
por: Zannoli, Silvia, et al.
Publicado: (2023)

Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
por: Destras, Grégory, et al.
Publicado: (2022)

Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2022)

Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts
por: Ko, Karrie K. K., et al.
Publicado: (2022)

Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications
por: Spinicci, Michele, et al.
Publicado: (2022)

Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma
por: Borges, Vítor, et al.
Publicado: (2021)

Viral dynamics of SARS-CoV-2 in immunocompromised patients
por: Utzon, Andrea N., et al.
Publicado: (2023)

Atypical presentations of MERS-CoV infection in immunocompromised hosts
por: Kim, Si-Ho, et al.
Publicado: (2017)

Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient
por: Nakajima, Yukiko, et al.
Publicado: (2021)

491. Persistence of SARS-CoV-2 Iinfection in Immunocompromised Children
por: Dolan, Susan, et al.
Publicado: (2021)

Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host
por: Caccuri, Francesca, et al.
Publicado: (2022)

Comprehensive Analysis of Disease Pathology in Immunocompetent and Immunocompromised Hosts following Pulmonary SARS-CoV-2 Infection
por: Ramasamy, Santhamani, et al.
Publicado: (2022)

Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
por: Aguilar-Bretones, Muriel, et al.
Publicado: (2023)

Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment
por: Chen, Liang, et al.
Publicado: (2021)

Evolution of the SARS-CoV-2 spike protein in the human host
por: Wrobel, Antoni G., et al.
Publicado: (2022)

1064. Intra-Host SARS-CoV-2 Evolution Dynamics
por: Haddad, Kim El, et al.
Publicado: (2022)

Host Immune Response Driving SARS-CoV-2 Evolution
por: Wang, Rui, et al.
Publicado: (2020)

Paxlovid in patients who are immunocompromised and hospitalised with SARS-CoV-2 infection
por: Sun, Fangfang, et al.
Publicado: (2022)

SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy
por: Truffot, Aurélie, et al.
Publicado: (2021)

464. Whole Genome Sequencing and Mutation Analysis of SARS-CoV-2 in the Immunocompromised Patients with Persistent SARS-CoV-2 Shedding
por: Chang, Eui Jin, et al.
Publicado: (2023)

Host heterogeneity and epistasis explain punctuated evolution of SARS-CoV-2
por: Nielsen, Bjarke Frost, et al.
Publicado: (2023)

Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

456. Within-host Viral Evolution and Neutralizing Antibody Response in Immunocompromised Patients with Persistent SARS-CoV-2 Infection Receiving B Cell Depleting Treatment
por: Ahn, Sangmin, et al.
Publicado: (2023)

Secondary organising pneumonia to persistent SARS-CoV-2 infection in immunocompromised patient
por: Granados, Galo David, et al.
Publicado: (2022)

Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals
por: Gioia, Francesca, et al.
Publicado: (2022)

Evaluation of the Elecsys SARS-CoV-2 antigen assay for the detection of SARS-CoV-2 in nasopharyngeal swabs.
por: Ben Abdelhanin, Myriam, et al.
Publicado: (2021)

Within-Host and Between-Host Evolution in SARS-CoV-2—New Variant’s Source
por: Moelling, Karin
Publicado: (2021)

Intra-host evolution during SARS-CoV-2 prolonged infection
por: Voloch, Carolina M, et al.
Publicado: (2021)

Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center
por: Freeman, Megan Culler, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vbmbhsv36m8a5qbon7dfagtha5